Anthem Biosciences had a robust launch on the stock exchanges today. On the NSE, the stock began trading at ₹723.05 each, ...

Anthem Biosciences debuted on the stock market on July 21, listing at ₹723.05 on NSE, a 26.85% premium over its IPO price.

Anthem Biosciences IPO listing was in line with the Street estimates as indicated by the grey market premium (GMP). Anthem ...

Contract research, development, and manufacturing organisation Anthem Biosciences shares recorded healthy returns on its ...

Key Details and Listing Information<br />The bidding for the Anthem Biosciences Initial Public Offering (IPO) took place from ...

Anthem’s IPO did not include a fresh issue, with all proceeds going to existing shareholders. Prior to the IPO opening, ...

Anthem Biosciences Ltd ended its debut trading day with a premium of over 28%. Despite the high opening figures, the company ...

Anthem Biosciences shares listed on the stock exchanges on Monday with a premium of about 27 percent over it's initial public ...

Anthem Biosciences share price on the BSE was trading at Rs. 730.70, up Rs. 7.60 or 1.05% from the listing price and a 28.19% ...

Analysts said that Anthem Biosciences' IPO was fairly priced, supported by strong growth, industry-leading margins, and ...

Anthem Biosciences, a leading contract research and manufacturing organization (CRDMO), made a strong debut on the Indian ...

Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, ...